USD 15.97
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 61.3 Billion JPY | 1.1% |
2023 | 66.54 Billion JPY | 8.54% |
2022 | 61.3 Billion JPY | 20.65% |
2021 | 50.81 Billion JPY | 6.67% |
2020 | 47.63 Billion JPY | 0.71% |
2019 | 47.3 Billion JPY | -13.69% |
2018 | 54.8 Billion JPY | 6.16% |
2017 | 51.62 Billion JPY | -6.75% |
2016 | 55.35 Billion JPY | 3.7% |
2015 | 53.38 Billion JPY | -4.61% |
2014 | 55.96 Billion JPY | 9.9% |
2013 | 50.92 Billion JPY | 15.25% |
2012 | 44.18 Billion JPY | 10.19% |
2011 | 40.09 Billion JPY | 11.91% |
2010 | 35.83 Billion JPY | -0.6% |
2009 | 36.04 Billion JPY | -1.09% |
2008 | 36.44 Billion JPY | 2.01% |
2007 | 35.72 Billion JPY | 10533.63% |
2006 | 336 Million JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 61.3 Billion JPY | -7.87% |
2024 Q1 | 16.68 Billion JPY | -2.79% |
2024 Q2 | 16.38 Billion JPY | -1.82% |
2024 Q3 | 16.64 Billion JPY | 1.57% |
2024 Q4 | 17.41 Billion JPY | 4.68% |
2023 Q3 | 16.82 Billion JPY | 3.63% |
2023 FY | 66.54 Billion JPY | 8.54% |
2023 Q4 | 17.16 Billion JPY | 2.02% |
2023 Q1 | 16.31 Billion JPY | -7.66% |
2023 Q2 | 16.23 Billion JPY | -0.48% |
2022 Q1 | 13.12 Billion JPY | -4.77% |
2022 Q2 | 14.82 Billion JPY | 12.93% |
2022 FY | 61.3 Billion JPY | 20.65% |
2022 Q3 | 15.68 Billion JPY | 5.79% |
2022 Q4 | 17.66 Billion JPY | 12.64% |
2021 Q1 | 11.42 Billion JPY | -2.36% |
2021 Q4 | 13.78 Billion JPY | 2.37% |
2021 Q3 | 13.46 Billion JPY | 10.95% |
2021 FY | 50.81 Billion JPY | 6.67% |
2021 Q2 | 12.13 Billion JPY | 6.25% |
2020 FY | 47.63 Billion JPY | 0.71% |
2020 Q1 | 11.66 Billion JPY | 0.47% |
2020 Q2 | 12.09 Billion JPY | 3.66% |
2020 Q3 | 12.18 Billion JPY | 0.78% |
2020 Q4 | 11.7 Billion JPY | -3.97% |
2019 Q4 | 11.6 Billion JPY | 2.44% |
2019 Q3 | 11.33 Billion JPY | -4.19% |
2019 FY | 47.3 Billion JPY | -13.69% |
2019 Q1 | 12.53 Billion JPY | 0.43% |
2019 Q2 | 11.82 Billion JPY | -5.64% |
2018 Q2 | 14.11 Billion JPY | 3.39% |
2018 Q4 | 12.48 Billion JPY | -14.29% |
2018 Q1 | 13.64 Billion JPY | 1.31% |
2018 FY | 54.8 Billion JPY | 6.16% |
2018 Q3 | 14.56 Billion JPY | 3.19% |
2017 Q2 | 12.49 Billion JPY | -5.69% |
2017 FY | 51.62 Billion JPY | -6.75% |
2017 Q4 | 13.47 Billion JPY | 8.51% |
2017 Q3 | 12.41 Billion JPY | -0.6% |
2017 Q1 | 13.24 Billion JPY | -4.72% |
2016 Q2 | 14.06 Billion JPY | 2.02% |
2016 Q1 | 13.79 Billion JPY | 1.22% |
2016 Q4 | 13.9 Billion JPY | 2.22% |
2016 Q3 | 13.59 Billion JPY | -3.34% |
2016 FY | 55.35 Billion JPY | 3.7% |
2015 Q1 | 13.15 Billion JPY | -8.5% |
2015 FY | 53.38 Billion JPY | -4.61% |
2015 Q4 | 13.62 Billion JPY | 0.58% |
2015 Q3 | 13.54 Billion JPY | 3.71% |
2015 Q2 | 13.06 Billion JPY | -0.67% |
2014 Q4 | 14.37 Billion JPY | -0.4% |
2014 FY | 55.96 Billion JPY | 9.9% |
2014 Q1 | 13.41 Billion JPY | 1.24% |
2014 Q2 | 13.74 Billion JPY | 2.45% |
2014 Q3 | 14.43 Billion JPY | 4.98% |
2013 Q2 | 12.34 Billion JPY | -1.4% |
2013 Q4 | 13.25 Billion JPY | 3.44% |
2013 FY | 50.92 Billion JPY | 15.25% |
2013 Q1 | 12.51 Billion JPY | -7.75% |
2013 Q3 | 12.81 Billion JPY | 3.81% |
2012 FY | 44.18 Billion JPY | 10.19% |
2012 Q2 | 9.91 Billion JPY | -3.18% |
2012 Q3 | 10.45 Billion JPY | 5.47% |
2012 Q4 | 13.56 Billion JPY | 29.73% |
2012 Q1 | 10.24 Billion JPY | -2.38% |
2011 Q4 | 10.49 Billion JPY | -2.85% |
2011 FY | 40.09 Billion JPY | 11.91% |
2011 Q1 | 9.32 Billion JPY | 3.73% |
2011 Q3 | 10.8 Billion JPY | 13.9% |
2011 Q2 | 9.48 Billion JPY | 1.72% |
2010 Q3 | 9.02 Billion JPY | 2.56% |
2010 Q1 | 9.02 Billion JPY | 5.03% |
2010 Q4 | 8.98 Billion JPY | -0.38% |
2010 FY | 35.83 Billion JPY | -0.6% |
2010 Q2 | 8.79 Billion JPY | -2.55% |
2009 Q4 | 8.59 Billion JPY | -4.0% |
2009 Q3 | 8.95 Billion JPY | -2.91% |
2009 Q2 | 9.22 Billion JPY | 0.0% |
2009 FY | 36.04 Billion JPY | -1.09% |
2008 FY | 36.44 Billion JPY | 2.01% |
2007 FY | 35.72 Billion JPY | 10533.63% |
2006 FY | 336 Million JPY | 0.0% |
2005 Q4 | - JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Bio Medica Corporation | 1.04 Million USD | -5844323.26% |
Arrayit Corporation | 6.19 Million USD | -989125.465% |
Atlantic International Corp. | 5.57 Million USD | -1098949.437% |
Biocept, Inc. | 29.4 Million USD | -208423.52% |
Bioqual, Inc. | 7.44 Million USD | -822961.952% |
CardioGenics Holdings Inc | 772.14 Thousand USD | -7939890.313% |
DermTech, Inc. | 104.01 Million USD | -58841.499% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | -36721.348% |
HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -270890.372% |
iMD Companies, Inc. | 151.8 Thousand USD | -40384857.414% |
IDenta Corp. | 662.97 Thousand USD | -9247307.519% |
Interpace Biosciences, Inc. | 20.23 Million USD | -302924.911% |
Integrative Health Technologies, Inc. | 38.88 Thousand USD | -157681029.601% |
InVitro International | 661.32 Thousand USD | -9270393.737% |
Lumos Diagnostics Holdings Limited | 7.09 Million USD | -863636.264% |
Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -105499624.67% |
Medical Imaging Corp. | 1.91 Million USD | -3206110.346% |
NovelStem International Corp. | 3.53 Million USD | -1732841.866% |
Optigenex Inc. | 1.28 Million USD | -4760322.062% |
PharmChem, Inc. | 2.93 Million USD | -2091445.901% |
Proteome Sciences plc | 3.26 Million USD | -1875909.792% |
Response Genetics, Inc | 25.31 Million USD | -242042.265% |
Rennova Health, Inc. | 7.67 Million USD | -798411.55% |
RushNet, Inc. | 1.78 Million USD | -3426229.555% |
ScreenPro Security Inc. | 3.23 Million USD | -1892757.264% |
Stella Diagnostics Inc. | 11.42 Million USD | -536421.119% |
StageZero Life Sciences Ltd. | 7.34 Million USD | -834815.789% |
Todos Medical Ltd. | 14.05 Million USD | -436007.554% |